130 related articles for article (PubMed ID: 18201362)
1. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.
Bogunia-Kubik K; Mazur G; Wróbel T; Kuliczkowski K; Lange A
Tissue Antigens; 2008 Feb; 71(2):146-50. PubMed ID: 18201362
[TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A
J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
[TBL] [Abstract][Full Text] [Related]
5. Functional association of interleukin 18 gene -607 (C/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease.
Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
J Rheumatol; 2009 Oct; 36(10):2284-9. PubMed ID: 19684151
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.
Kube D; Hua TD; Klöss M; Kulle B; Brockmöller J; Wojnowski L; Löffler M; Pfreundschuh M; Trümper L
Genes Immun; 2007 Mar; 8(2):164-7. PubMed ID: 17215862
[TBL] [Abstract][Full Text] [Related]
7. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
8. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.
Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M
Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157
[TBL] [Abstract][Full Text] [Related]
9. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
Romero JM; Sáenz-López P; Cózar JM; Carretero R; Canton J; Vazquez F; Concha A; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2009 Jan; 70(1):60-4. PubMed ID: 19027043
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas.
Bel Hadj Jrad B; Chatti A; Laatiri A; Ahmed SB; Romdhane A; Ajimi S; Chouchane L
Eur J Haematol; 2007 Feb; 78(2):117-22. PubMed ID: 17087739
[TBL] [Abstract][Full Text] [Related]
11. [The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas].
Juszczyński P; Kalinka E; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffiers B; Salles G; Warzocha K
Przegl Lek; 2005; 62(12):1417-21. PubMed ID: 16786763
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Köppel H; Wascher TC; Paulweber B; Samonigg H
Breast Cancer Res Treat; 2005 Mar; 90(2):113-5. PubMed ID: 15803357
[TBL] [Abstract][Full Text] [Related]
13. Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms.
Domingo-Domènech E; Benavente Y; González-Barca E; Montalban C; Gumà J; Bosch R; Wang SS; Lan Q; Whitby D; Fernández de Sevilla A; Rothman N; de Sanjosé S
Haematologica; 2007 Nov; 92(11):1475-81. PubMed ID: 18024395
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.
Cunningham LM; Chapman C; Dunstan R; Bell MC; Joske DJ
Leuk Lymphoma; 2003 Feb; 44(2):251-5. PubMed ID: 12688341
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
Monne M; Piras G; Palmas A; Arru L; Murineddu M; Latte G; Noli A; Gabbas A
Am J Hematol; 2004 May; 76(1):14-8. PubMed ID: 15114591
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.
Rosado S; Rua-Figueroa I; Vargas JA; Garcia-Laorden MI; Losada-Fernandez I; Martin-Donaire T; Perez-Chacon G; Rodriguez-Gallego C; Naranjo-Hernandez A; Ojeda-Bruno S; Citores MJ; Perez-Aciego P
Int J Immunogenet; 2008 Jun; 35(3):235-42. PubMed ID: 18397303
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma.
Hohaus S; Giachelia M; Massini G; Vannata B; Criscuolo M; Martini M; D'Alo' F; Voso MT; Larocca LM; Leone G
Leuk Res; 2009 Oct; 33(10):1352-6. PubMed ID: 19201467
[TBL] [Abstract][Full Text] [Related]
18. IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma.
Mazur G; Bogunia-Kubik K; Wróbel T; Karabon L; Polak M; Kuliczkowski K; Lange A
Immunol Lett; 2005 Jan; 96(2):241-6. PubMed ID: 15585329
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 promoter polymorphisms in giant cell arteritis.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Catanoso MG; Pattacini L; Salvarani C
Arthritis Rheum; 2006 Dec; 54(12):4011-7. PubMed ID: 17133531
[TBL] [Abstract][Full Text] [Related]
20. Heterozygote AG variant of -596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL).
Vasku JA; Vasku A; Goldbergova M; Vasku V
Clin Immunol; 2004 Dec; 113(3):256-60. PubMed ID: 15507390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
